These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 29101186)
1. BP Reduction, Kidney Function Decline, and Cardiovascular Events in Patients without CKD. Magriço R; Bigotte Vieira M; Viegas Dias C; Leitão L; Neves JS Clin J Am Soc Nephrol; 2018 Jan; 13(1):73-80. PubMed ID: 29101186 [TBL] [Abstract][Full Text] [Related]
3. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events. Rathi N; Whelton PK; Chertow GM; Cushman WC; Cheung AK; Wei G; Boucher R; Kimmel PL; Bress AP; Kramer HJ; Al-Marji C; Greene T; Beddhu S Am J Hypertens; 2019 Nov; 32(12):1170-1177. PubMed ID: 31257407 [TBL] [Abstract][Full Text] [Related]
4. Initial Estimated Glomerular Filtration Rate Decline and Long-Term Renal Function During Intensive Antihypertensive Therapy: A Post Hoc Analysis of the SPRINT and ACCORD-BP Randomized Controlled Trials. Collard D; Brouwer TF; Olde Engberink RHG; Zwinderman AH; Vogt L; van den Born BH Hypertension; 2020 May; 75(5):1205-1212. PubMed ID: 32223381 [TBL] [Abstract][Full Text] [Related]
5. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial. Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803 [TBL] [Abstract][Full Text] [Related]
6. Effect of Intensive Blood Pressure Control on Kidney Outcomes: Long-Term Electronic Health Record-Based Post-Trial Follow-Up of SPRINT. Drawz PE; Lenoir KM; Rai NK; Rastogi A; Chu CD; Rahbari-Oskoui FF; Whelton PK; Thomas G; McWilliams A; Agarwal AK; Suarez MM; Dobre M; Powell J; Rocco MV; Lash JP; Oparil S; Raj DS; Dwyer JP; Rahman M; Soman S; Townsend RR; Pemu P; Horwitz E; Ix JH; Tuot DS; Ishani A; Pajewski NM Clin J Am Soc Nephrol; 2024 Feb; 19(2):213-223. PubMed ID: 37883184 [TBL] [Abstract][Full Text] [Related]
7. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials. Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268 [TBL] [Abstract][Full Text] [Related]
8. Relationship between blood pressure and incident chronic kidney disease in hypertensive patients. Hanratty R; Chonchol M; Havranek EP; Powers JD; Dickinson LM; Ho PM; Magid DJ; Steiner JF Clin J Am Soc Nephrol; 2011 Nov; 6(11):2605-11. PubMed ID: 21921154 [TBL] [Abstract][Full Text] [Related]
9. Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials. Beddhu S; Greene T; Boucher R; Cushman WC; Wei G; Stoddard G; Ix JH; Chonchol M; Kramer H; Cheung AK; Kimmel PL; Whelton PK; Chertow GM Lancet Diabetes Endocrinol; 2018 Jul; 6(7):555-563. PubMed ID: 29685860 [TBL] [Abstract][Full Text] [Related]
10. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey). Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605 [TBL] [Abstract][Full Text] [Related]
11. Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial. Davis EM; Appel LJ; Wang X; Greene T; Astor BC; Rahman M; Toto R; Lipkowitz MS; Pogue VA; Wright JT; Hypertension; 2011 Jun; 57(6):1061-8. PubMed ID: 21555676 [TBL] [Abstract][Full Text] [Related]
12. Effects of Intensive BP Control in CKD. Cheung AK; Rahman M; Reboussin DM; Craven TE; Greene T; Kimmel PL; Cushman WC; Hawfield AT; Johnson KC; Lewis CE; Oparil S; Rocco MV; Sink KM; Whelton PK; Wright JT; Basile J; Beddhu S; Bhatt U; Chang TI; Chertow GM; Chonchol M; Freedman BI; Haley W; Ix JH; Katz LA; Killeen AA; Papademetriou V; Ricardo AC; Servilla K; Wall B; Wolfgram D; Yee J; J Am Soc Nephrol; 2017 Sep; 28(9):2812-2823. PubMed ID: 28642330 [TBL] [Abstract][Full Text] [Related]
14. Blood pressure targets in adults with hypertension. Arguedas JA; Leiva V; Wright JM Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004349. PubMed ID: 33332584 [TBL] [Abstract][Full Text] [Related]
15. Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial. Peralta CA; McClure LA; Scherzer R; Odden MC; White CL; Shlipak M; Benavente O; Pergola P Circulation; 2016 Feb; 133(6):584-91. PubMed ID: 26762524 [TBL] [Abstract][Full Text] [Related]
16. Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial. Beddhu S; Rocco MV; Toto R; Craven TE; Greene T; Bhatt U; Cheung AK; Cohen D; Freedman BI; Hawfield AT; Killeen AA; Kimmel PL; Lash J; Papademetriou V; Rahman M; Rastogi A; Servilla K; Townsend RR; Wall B; Whelton PK; Ann Intern Med; 2017 Sep; 167(6):375-383. PubMed ID: 28869987 [TBL] [Abstract][Full Text] [Related]
17. Association between blood pressure variability and risk of kidney function decline in hypertensive patients without chronic kidney disease: a post hoc analysis of Systolic Blood Pressure Intervention Trial study. Wang Z; Li W; Jiang C; Wang J; Hua C; Tang Y; Zhang H; Liu X; Wang Y; Gao M; Lv Q; Dong J; Ma C; Du X J Hypertens; 2024 Jul; 42(7):1203-1211. PubMed ID: 38690929 [TBL] [Abstract][Full Text] [Related]
18. Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT. Beddhu S; Shen J; Cheung AK; Kimmel PL; Chertow GM; Wei G; Boucher RE; Chonchol M; Arman F; Campbell RC; Contreras G; Dwyer JP; Freedman BI; Ix JH; Kirchner K; Papademetriou V; Pisoni R; Rocco MV; Whelton PK; Greene T J Am Soc Nephrol; 2019 Aug; 30(8):1523-1533. PubMed ID: 31324734 [TBL] [Abstract][Full Text] [Related]
19. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial). Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269 [TBL] [Abstract][Full Text] [Related]
20. Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial. Malhotra R; Katz R; Weiner DE; Levey AS; Cheung AK; Bostom AG; Ix JH Am J Hypertens; 2019 Aug; 32(9):816-823. PubMed ID: 31179500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]